Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:52 AM
Ignite Modification Date:
2025-12-25 @ 4:52 AM
NCT ID:
NCT03548818
Eligibility Criteria:
Inclusion Criteria:
* Current treatment with IFN-γ or intent to treat with this drug
* Acute infections resolved
* Subject is off treatment medications
* Women of childbearing potential must have:
* a negative urine beta-HCG, and
* be willing to practice two forms of effective contraception for the duration of study participation
Exclusion Criteria:
* Pregnancy,
* Breast-feeding, or
* Unwillingness to use effective contraception
* Recent vaccination (within the last fourteen days)
* Current infection or acute health condition requiring treatment
* Chronic inflammatory complications of CGD including:
* gastric outlet or urinary tract obstruction,
* pleuritis,
* pericarditis,
* inflammatory bowel disease, or
* colitis requiring treatment.
* Un-associated chronic lung, liver, kidney, or cardiac disorders requiring active treatment
Sex:
ALL
Minimum Age:
5 Years
Maximum Age:
60 Years
Study:
NCT03548818
Study Brief:
Protocol Section:
NCT03548818